| 查看: 343 | 回复: 0 | |||
lubenle至尊木虫 (知名作家)
|
[交流]
FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用
|
|
Use of Aspirin for Primary Prevention of Heart Attack and Stroke http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用, 但对于有心脏病或中风史的人服用阿斯匹灵有预防再次发作的作用! [05/02/2014] Cardiovascular disease, including heart disease and stroke, affects tens of millions of people in the United States. Consumers and patients who do not suffer from cardiovascular disease sometimes consider taking aspirin to reduce the possibility of having a heart attack or stroke. Reducing the possibility of having a first heart attack or stroke is called primary prevention. The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke. In fact, there are serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain, in situations where the benefit of aspirin for primary prevention has not been established. The available evidence supports the use of aspirin for preventing another heart attack or stroke in patients who have cardiovascular disease or who have already had a heart attack or stroke. Reducing the risk of additional heart attacks or strokes is known as secondary prevention. In patients who have had a cardiovascular event, the known benefits of aspirin for secondary prevention outweigh the risk of bleeding. |
» 猜你喜欢
353公卫求调剂
已经有0人回复
27博士自推荐
已经有0人回复
内分泌系统/代谢和营养支持论文润色/翻译怎么收费?
已经有267人回复
27申博
已经有10人回复
公共卫生2027申博
已经有20人回复
【2027申博自荐】公共卫生硕士|R统计分析/临床科研数据处理|寻求博士机会
已经有0人回复











回复此楼